Background: Clinical studies on the impact of dexmedetomidine on tourniquet-induced systemic effects have been inconsistent. We investigated the impact of dexmedetomidine on tourniquet-induced systemic effects in total knee arthroplasty.
Methods: Eighty patients were randomly assigned to either control (CON) or dexmedetomidine (DEX) group.